Immunodiagnostics Market Size Worth US$ 39.36 Billion by 2030 at 7.40% CAGR, COVID-19 Impact and Global Analysis by Growth Plus Reports

News provided by

Oct 06, 2022, 09:30 ET

NEW YORK, Oct. 6, 2022 /PRNewswire/ -- According to the latest report published by Growth Plus Reports, the global Immunodiagnostics Market is expected to clock at US$ 39.36 billion by 2030 and to grow at a CAGR of 7.40% during the forecast period. This exclusive information is published by growth plus reports in its report titled "Immunodiagnostics Market – Global Outlook & Forecast 2022-2030"

The recent technological advancements have led to growing the introduction of effective and advanced immunodiagnostic products globally. Latest of such advancement in immunodiagnostics is the development of bead AlphaLISA by Perkin Elmer, which has significantly decreased the complexity and length of immunoassays. A streptavidin-coated Alpha donor bead and an anti-analyte-conjugated AlphaLISA acceptor bead are used, and they are brought close together to produce the signal when the analyte is present. These non-washing chemiluminescent immunoassays have higher sensitivity, a wider dynamic range, and better analytical performance than traditional ELISA (Enzyme- Linked Immunoassay).

Download Free Sample Report Now @ https://growthplusreports.com/inquiry/request-sample/immunodiagnostics-market/7837

Market Drivers
The rising incidence of chronic diseases including cancer, gastrointestinal disorders, cardiovascular diseases, and infectious diseases like HIV, hepatitis B, and others is one of the main factors driving the global market for immunodiagnostics. Additionally, technical developments are resulting in the development of advanced diagnostic kits, which is increasing public awareness. Strict government regulations delaying commercialization of novel solutions, however, can restrain the expansion of the global immunodiagnostics market.

Excerpts from 'by Application'
The global immunodiagnostics market is segmented into:

Oncology
Endocrinology
Hepatitis
Retrovirus Testing
Gi Stool Testing
Infectious Disease Testing
Others

The global market has been driven by the oncology sector. Immunodiagnostics provide a better understanding of how the immune system responds when cancer evolves. Additionally, utilizing this method makes consideration of immunosurveillance simplified. Other segments like endocrinology and hepatitis might also benefit the market growth throughout the prediction period.

Speak to our Analyst to Understand the Impact of COVID-19 on Your Business: https://growthplusreports.com/inquiry/speak-analyst/immunodiagnostics-market/7837

Excerpts from 'by Technology'

The immunodiagnostics market is divided into four categories based on technology:

Fluorescent Immunoassay
Chemiluminescence Immunoassay
Radioimmunoassay
Enzyme-Linked Immunosorbent Assay

The immunofluorescence assays (IFAs) are described with high assay sensitivity by utilizing an antibody that has been fluorescently marked and can be seen under a fluorescence microscope. IFA testing, can be performed on tissue slices or blood smears, enables the localization of the source of the positive signal. IFA are frequently used to find anti-infectious agent antibodies. The market for immunodiagnostics will eventually grow since infectious diseases are projected to show lucrative growth. An antibody is linked to an enzyme in ELISAs (enzyme linked immunosorbent assays), which, when exposed to a substrate, changes color and aids diagnosis. Radioimmunoassay is frequently used in tests for cortisol, thyroid hormones, and cyclosporine which means that as these disorders become more prevalent, the market for immunodiagnostics will eventually grow.

Excerpts from 'by Region'
The global market for immunodiagnostics is divided into four geographic segments:

North America
Europe
Asia Pacific
Rest of the world

Asia Pacific holds dominating position in terms of revenue share. The prevalence of many chronic diseases is increasing, many new products are getting approved, and presence of reimbursement activities, are all factors which contributes to the regional market growth. Additionally, a growing elderly population with chronic diseases raises increases the need for routine examinations. The prevalence of chronic diseases like cancer, gastrointestinal problems, and infectious diseases is on the rise in the North American region. These factors, along with the availability of disease-specific immunodiagnostic tests and advancements in immunodiagnostic technology, all contribute to the market growth in North America. Growing numbers of elderly people with chronic diseases and the development of sophisticated diagnostic systems due to technical advancements are factors in the expansion of Europe market.

Excerpts from 'Competitive Landscape'
Some of the prominent players operating in the global immunodiagnostics market are

Johnson & Johnson Services, Inc
F. Hoffman-La Roche Ltd
Diasorin S.P.A
Danaher Corporation Sysmex Corporation
Thermo Fisher Scientific, Inc
Bio-Rad Laboratories, Inc
Siemens AG Immunodiagnostics Systems Holdings Plc
Arkray, Inc
bioMérieux SA
Abbott Laboratories Inc

Table of Content

INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years – 2020
2. Base Year – 2021
3. Forecasted Years – 2022 to 2030
Currency Used in the Report
RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
PREMIUM INSIGHTS
1. Current Market Trends (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
GLOBAL IMMUNODIAGNOSTICS MARKET - ANALYSIS & FORECAST, BY APPLICATION
1. Oncology
2. Endocrinology
3. Hepatitis
4. Retrovirus Testing
5. GI Stool Testing
6. Infectious Disease Testing
7. Others

TOC Continued….

VALUE PROPOSITIONS RELATED TO THE REPORT:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

Distributor Landscape Assessment
Pricing Intelligence
Customer Base Assessment
Investment & Initiatives Analysis
'Business Profile' of Key Players

Directly Purchase Premium Copy of Immunodiagnostics Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=wcORUxLJ2fikWvWz8I0nY0HcTBdHwD2Yy8LM4wU2&report_id=7837&license=Single

About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

Contact:
Manan Sethi
Director, Market Insights
Email: [email protected]
Phone no: +91 96545 76783
Web: https://growthplusreports.com/
Follow Us: LinkedIn | Twitter

Logo - https://mma.prnewswire.com/media/1671244/Growth_Plus_Reports_Logo.jpg

SOURCE Growth Plus Reports